Organizations Filed Purposes:
THE MISSION OF THE MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM, INC. (THE CONSORTIUM) IS TO ACCELERATE THE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES - BASIC, TRANSLATIONAL AND CLINICAL SCIENCE - TO EXPEDITE DEVELOPMENT OF COMBINATIONS OF THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRE-CLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS A NEW THERAPEUTIC TARGET.
SUPPORTS CLINICAL TRIALS, DRUG DEVELOP. & RESEARCH RELATING TO TREATMENT & PREVENTION OF MELANOMA.
THE CONSORTIUM SEEKS TO ACCELERATE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. SUCCESS IN THIS ENDEAVOR ALSO FURTHERS THE EXEMPT PURPOSE OF THE MELANOMA RESEARCH FOUNDATION (MRF). IN ORDER TO ACHIEVE ITS MISSION, THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES- BASIC, TRANSLATIONAL AND CLINICAL SCIENCE- TO EXPEDITE DEVELOPMENT OF COMBINATION THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRECLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS NEW THERAPEUTIC TARGETS WHICH REQUIRED THE EXPERTISE OF A MD AND PROJECT MANAGER. IN ADDITION, THE CONSORTIUM'S BOARD OF DIRECTORS AND PARTICIPATING RESEARCH INSTITUTIONS WILL CONDUCT OUTREACH TO MULTI SECTOR PARTNERS WITH AN INTEREST OR INVESTMENT IN MELANOMA RESEARCH TO ENSURE THAT THE CONSORTIUM IS AWARE OF ANY IMPORTANT DEVELOPMENTS OR PROMISING RESEARCH IN THE FIELD OF MELANOMA.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Ze'Ev Ronai Phd | BOARD MEMBER | 1 | $0 |
| Alison Martin | BOARD MEMBER | 1 | $0 |
| Jeffrey E Gershenwald Md | BOARD MEMBER | 1 | $0 |
| Keith T Flaherty Md | BOARD MEMBER | 1 | $0 |
| Michael B Atkins Md | BOARD MEMBER | 1 | $0 |
| Anthony T Hendrickson | TREASURER & CFO | 1 | $0 |
| Meenhard Herlyn Dvm Dsc | SECRETARY - UNTIL 09/2019 | 1 | $0 |
| Lynn Schuchter Md Executive | VICE PRESIDENT - UNTIL 09/2019 | 1 | $0 |
| Steve Silverstein | CHAIRMAN & PRESIDENT | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202002929349300400_public.xml